Development of recombinant canine adenovirus type-2 expressing the Gn glycoprotein of Seoul virus

被引：2

作者：

Yuan, Ziguo ^{[1
,2
]}

Zhang, Xiuxiang ^{[2
]}

Zhang, Shoufeng ^{[1
]}

Liu, Ye ^{[1
]}

Gao, Shengyan ^{[3
]}

Zhang, Fei ^{[1
]}

Xu, Huijuan ^{[2
]}

Wang, Xiaohu ^{[2
]}

Hu, Rongliang ^{[1
]}

机构：

[1] Acad Mil Med Sci, Vet Inst, Lab Epidemiol, Changchun 130062, Peoples R China

[2] Jilin Univ, Div Agr, Coll Anim Sci & Vet Med, Changchun 130062, Peoples R China

[3] Jilin Agr Univ, Coll Life Sci, Changchun 130062, Peoples R China

来源：

BIOLOGICALS | 2008年 / 36卷 / 03期

关键词：

hantavirus; Seoul virus; canine adenovirus type-2; Gn;

D O I：

10.1016/j.biologicals.2007.10.003

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Seoul virus glycoprotein Gn is a major structural protein and candidate antigen of hantavirus that induces a highly immunogenic response for hantavirus vaccine. In this study, a replication-competent recombinant canine adenovirus type-2 expressing Gn was constructed by the in vitro ligation method. The Gn expression cassette, including the human cytomegalovirus (hCMV) promoter/enhancer and the SV40 early mRNA polyadenylation signal, was cloned into the SspI site of the E3 region which is not essential for proliferation of CAV-2. Expression of Gn was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. (C) 2007 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

引用

页码：162 / 167

页数：6

共 50 条

[31] Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice
Li, Xiu-Zhen
Wang, Xiao-Hu
Xia, Li-Jun
Weng, Ya-Biao
Hernandez, Jorge A.
Tu, Li-Qing
Li, Lu-Tao
Li, Shou-Jun
Yuan, Zi-Guo
BMC INFECTIOUS DISEASES, 2015, 15
[32] Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice
Xiu-Zhen Li
Xiao-Hu Wang
Li-Jun Xia
Ya-Biao Weng
Jorge A Hernandez
Li-Qing Tu
Lu-Tao Li
Shou-Jun Li
Zi-Guo Yuan
BMC Infectious Diseases, 15
[33] EXPRESSION OF ADENOVIRUS TYPE-2 LATE GENES IN HELA-CELLS INFECTED WITH ADENOVIRUS TYPE-2 OR ADENOVIRUS TYPE-2-SIMIAN VIRUS-40 HYBRID VIRUSES
LAWRENCE, CB
JOURNAL OF VIROLOGY, 1981, 40 (02) : 610 - 614
[34] USE OF CANINE ADENOVIRUS TYPE-2 VACCINE TO CONTROL KENNEL COUGH SYNDROME
POWELL, KW
VETERINARY MEDICINE & SMALL ANIMAL CLINICIAN, 1979, 74 (06): : 801 - 804
[35] Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein
Pinschewer, DD
Perez, M
Sanchez, AB
de la Torre, JC
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) : 7895 - 7900
[36] UNCOATING OF ADENOVIRUS TYPE-2
MIRZA, MAA
WEBER, J
JOURNAL OF VIROLOGY, 1979, 30 (02) : 462 - 471
[37] HUMAN ADENOVIRUS TYPE-2
GILARDI, P
BULLETIN DU CANCER, 1989, 76 (04) : 418 - 419
[38] Human adenovirus type 5 vectors expressing rabies glycoprotein
Yarosh, OK
Wandeler, AI
Graham, FL
Campbell, JB
Prevec, L
VACCINE, 1996, 14 (13) : 1257 - 1264
[39] IMMUNIZATION WITH RECOMBINANT VARICELLA-ZOSTER VIRUS EXPRESSING HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN-D REDUCES THE SEVERITY OF GENITAL HERPES IN GUINEA-PIGS
HEINEMAN, TC
CONNELLY, BL
BOURNE, N
STANBERRY, LR
COHEN, J
JOURNAL OF VIROLOGY, 1995, 69 (12) : 8109 - 8113
[40] Comparison of live attenuated and inactivated canine adenovirus type-2 vaccines against infectious canine hepatitis
Reddy, GS
Srinivasan, VA
Bruckner, LS
Ramakrishna, J
INDIAN VETERINARY JOURNAL, 2002, 79 (06): : 543 - 545

← 1 2 3 4 5 →